-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Estrella Immunopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q1 2023 to Q3 2023.
- Estrella Immunopharma, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending September 30, 2023 was -$112K.
- Estrella Immunopharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $36.2M.